DE69332640D1 - Pharmazeutische pyridin-derivate - Google Patents

Pharmazeutische pyridin-derivate

Info

Publication number
DE69332640D1
DE69332640D1 DE69332640T DE69332640T DE69332640D1 DE 69332640 D1 DE69332640 D1 DE 69332640D1 DE 69332640 T DE69332640 T DE 69332640T DE 69332640 T DE69332640 T DE 69332640T DE 69332640 D1 DE69332640 D1 DE 69332640D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
pyridine derivatives
pct
sec
date jun
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332640T
Other languages
English (en)
Other versions
DE69332640T2 (de
Inventor
A Daines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
SmithKline Beecham Corp
Original Assignee
GlaxoSmithKline LLC
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC, SmithKline Beecham Corp filed Critical GlaxoSmithKline LLC
Application granted granted Critical
Publication of DE69332640D1 publication Critical patent/DE69332640D1/de
Publication of DE69332640T2 publication Critical patent/DE69332640T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69332640T 1992-06-30 1993-06-30 Pharmazeutische pyridin-derivate Expired - Fee Related DE69332640T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90677192A 1992-06-30 1992-06-30
US2519893A 1993-03-02 1993-03-02
PCT/US1993/006234 WO1994000437A1 (en) 1992-06-30 1993-06-30 Pharmaceutical pyridine compounds

Publications (2)

Publication Number Publication Date
DE69332640D1 true DE69332640D1 (de) 2003-02-20
DE69332640T2 DE69332640T2 (de) 2003-11-06

Family

ID=26699422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332640T Expired - Fee Related DE69332640T2 (de) 1992-06-30 1993-06-30 Pharmazeutische pyridin-derivate

Country Status (16)

Country Link
US (1) US5990314A (de)
EP (1) EP0649412B1 (de)
JP (1) JP3230682B2 (de)
KR (1) KR950702185A (de)
CN (1) CN1108247A (de)
AT (1) ATE231129T1 (de)
AU (2) AU4545893A (de)
CA (1) CA2138954A1 (de)
DE (1) DE69332640T2 (de)
ES (1) ES2191014T3 (de)
IL (1) IL106156A0 (de)
MA (1) MA22926A1 (de)
MX (1) MX9303973A (de)
NZ (1) NZ253967A (de)
SI (1) SI9300349A (de)
WO (1) WO1994000437A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT711282E (pt) 1993-07-28 2002-11-29 Aventis Pharma Ltd Compostos inibidores de pde iv e de fnt
AU1335795A (en) * 1993-12-08 1995-06-27 Smithkline Beecham Corporation Compounds
EP0732919A4 (de) * 1993-12-09 1997-05-02 Smithkline Beecham Corp Diphenyl-2-propenoate und homologe hiervon zur behandlung von erkrankungen, die mit leukotrien b4 verbunden sind
EP0812194B1 (de) * 1995-03-02 2000-08-16 Smithkline Beecham Corporation Verwendung von substituirten Pyridinverbindungen zur Behandlung der atopischen Dermatitis und der Kontaktdermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
CA2265996A1 (en) * 1996-09-26 1998-04-02 Roger Aki Fujimoto Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU655428B2 (en) * 1990-06-07 1994-12-22 Smithkline Beecham Corporation Benzoic acid derivatives
HUT64748A (en) * 1990-06-07 1994-02-28 Smithkline Beecham Corp Method for producing benzoic acid derivatives and pharmaceutical preparatives containing said compounds
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds

Also Published As

Publication number Publication date
EP0649412A1 (de) 1995-04-26
ATE231129T1 (de) 2003-02-15
KR950702185A (ko) 1995-06-19
EP0649412A4 (de) 1995-07-05
MA22926A1 (fr) 1994-04-01
JP3230682B2 (ja) 2001-11-19
MX9303973A (es) 1994-04-29
IL106156A0 (en) 1993-10-20
US5990314A (en) 1999-11-23
JPH07508284A (ja) 1995-09-14
AU2280797A (en) 1997-08-14
CN1108247A (zh) 1995-09-13
DE69332640T2 (de) 2003-11-06
EP0649412B1 (de) 2003-01-15
NZ253967A (en) 1996-11-26
AU707102B2 (en) 1999-07-01
AU4545893A (en) 1994-01-24
SI9300349A (sl) 1993-12-31
ES2191014T3 (es) 2003-09-01
CA2138954A1 (en) 1994-01-06
WO1994000437A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
DE59511017D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
BR9106432A (pt) Indolona neuroprotetora e derivados correlatos
ES2154270T3 (es) Nuevos derivados del imidazol, su preparacion y sus aplicaciones terapeuticas.
ATE124401T1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
ATE210147T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten(a- oder b-ring-verknüpfung)
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
EE9800318A (et) Leukotrieen-antagonistliku toimega bensopüraanderivaadid
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
DE69332640T2 (de) Pharmazeutische pyridin-derivate
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
FI944468A (fi) Sillastetut bis-aryylikarbinolijohdokset, seokset ja käyttömenetelmä
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
FR2700166B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
DE69705772D1 (de) Adamantyl substituierte Oxindole als pharmazeutische Wirkstoffe
NO974687D0 (no) Kondenserte <beta>-carboliner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee